Pyrazolo [3,4] pyrimidin-4-yl derivatives and their uses to treat diabetes and obesity
Details for Australian Patent Application No. 2009278929 (hide)
International Classifications
Event Publications
10 February 2011 PCT application entered the National Phase
PCT publication WO2010/015849 Priority application(s): WO2010/015849
10 March 2011 Corrigenda
PCT applications that have entered the National Phase - Name Index Under the name AstraZeneca AB, Application No. 2009278929, under INID (54) correct the title to Pyrazolo [3,4] pyrimidin-4-yl derivatives and their uses to treat diabetes and obesity
5 July 2012 Application Accepted
Published as AU-B-2009278929
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser